IL6 and chronic obstructive pulmonary disease: It was confirmed through in vitro and in vivo experiments that ergosterol reduces ROS, IL-6, and TNF-α, demonstrating anti-inflammatory and anti-senescence properties in managing chronic obstructive pulmonary disease (COPD) [45].